Business
Why the Polynovo (ASX:PNV) share price up 6% higher today // Motley Fool Australia
The Polynovo Ltd (ASX: PNV) share price is soaring higher today. This comes after the company announced an approval of a pivotal trial investigation device exemption (IDE).
During mid-morning trade, shares in the medical device company reached an intra-day high of $2.98. However, the Polynovo share price has since slightly retreated to $2.97, up 6.07% at the time of writing.
Let’s take a look at what Polynovo updated the market with.
FDA approval for clinical trial
Polynovo advised that the United States Food and Drug Administration (FDA) has approved the pivotal trial IDE for NovoSorb BTM. The authorisation allows Polynovo to begin patient recruitment, once various hospital Independent Review Boards grant approval.
Polynovo will…
-
Noosa News21 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General18 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General11 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General21 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity